APYX vs ED · rev $48.1M vs P/E 18, rev $15.26B
Apyx Medical Inc (APYX) versus Consolidated Edison Inc (ED) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
APYX currently screens at market cap $179.6M. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Not investment advice. Open the APYX and ED stock pages for the full models.
Not investment advice.